Mission statement · Company scope
“Our mission is to develop novel treatments for dormant cancers: targeting cancer resistance, metastasis, and relapse.”
In use2022 – now1 sighting
First seenDec 2022Added
Last seenDec 2022Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Product offering (primary) · Problem–solution · Innovation
- Leads with
- Product
- Best for
- Climate & health
- Formula
- We make [product] for [who]
- Tone
- Plain
- Length
- 16 words · reading grade 14.3
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.74
- Record
- st_20f7e3313868b106
- Classification confidence
- 0.59
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2022-12-08 · sec_sentence · S-1/A · accession 0001213900-22-078444
View filing ↗0 to compareCompare